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Composed of trillions of individual microbes, the human gut microbiota has adapted to
the uniquely diverse environments found in the human intestine. Quickly responding to
the variances in the ingested food, the microbiota interacts with the host via reciprocal
biochemical signaling to coordinate the exchange of nutrients and proper immune
function. Host andmicrobiota function as a unit which guards its balance against invasion
by potential pathogens and which undergoes natural selection. Disturbance of the
microbiota composition, or dysbiosis, is often associated with human disease, indicating
that, while there seems to be no unique optimal composition of the gut microbiota, a
balanced community is crucial for human health. Emerging knowledge of the ecology
of the microbiota-host synergy will have an impact on how we implement antibiotic
treatment in therapeutics and prophylaxis and how we will consider alternative strategies
of global remodeling of the microbiota such as fecal transplants. Here we examine the
microbiota-human host relationship from the perspective of the microbial community
dynamics.
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FOREWORD
This review is the result of a pedagogic initiative undertaken
during a third year Microbiology course at Concordia University
in Montréal. The project’s aim was to study the web of
interactions between the human host and its gut microbiota
by researching the latest discoveries and present it from the
perspective of the microorganisms. The initiative also aimed
at demonstrating to the students how to research the primary
literature and write an analytical, comprehensive and balanced
review. Choices on which original sources were cited were
exclusively dictated by the pedagogic scope and reach of the
course and in no way reflect considerations on the value of the
contributions that were excluded. We therefore apologize to all
the colleagues whose important research could not be cited due
to such constraints.
COMPOSITION OF THE HUMAN GUT
MICROBIOTA
The community of microorganisms residing in the human
gastrointestinal (GI) tract, the GI microbiota, is composed of
about one thousand commensal, and/or symbiotic microbial
species among which Viruses (including bacteriophages),
Bacteria, Archaea, and unicellular eukaryotes, comprising Fungi
and other non-bacterial and non-archaeal microbial species (Ley
et al., 2008; Gerritsen et al., 2011; Lozupone et al., 2012; Keeney
et al., 2014; Lagier et al., 2016). Difficulties in culturing some gut
microorganisms and discrepancies between the relative species
relationships observed in vivo and ex vivo has resulted in an
initial underestimate of the number of species in the human
gut microbiome, the list of microbial gene functions of the
GI tract (Lagier et al., 2015). Technological advances enabling
metagenomics and microbial identification via MALDI-TOF
mass spectrometry and the more recent implementation of
culturomics have expanded the known microbial community
of the human microbiome (Gill et al., 2006; Ley et al., 2006;
Seng et al., 2013; Hugon et al., 2015; Lagier et al., 2016). Under
normal healthy circumstances GI tract microbes can perform
beneficial tasks for the human host, e.g., food break down,
synthesis of vitamins and biomolecules and interaction with its
immune system. The GI environment, in turn, may support the
growth, reproduction and longevity of the bacterial community
(Lozupone et al., 2012; Browne et al., 2016). Changes in the
gut environment from diet and host physiology, as well as
ingested microbes, may create competition for resources that
affect the resident microbiota and may re-shape the microbial
community, which in turn may affect host physiology. Host
energy, metabolism and immunity have been found to respond
to cues from the GI microbiota and many human health
conditions have been linked with particular compositions of the
GI microbiome (Bäckhed et al., 2005; Robosky, 2005; Turnbaugh
et al., 2006; Rohde et al., 2007; Hibbing et al., 2010; Sommer and
Bäckhed, 2013).
The gut-associated microbiome was found to be relatively
conserved among several vertebrates including human, mouse,
and zebrafish and it was speculated that ancestral mammalian
species as early as the Jurassic period, relied on their gut-microbes
to support their mainly herbivorous diet (MacKie, 2002; Rawls
et al., 2004; Ley et al., 2008). It has been proposed that throughout
mammalian evolution carbohydrates became prominent energy
sources and the acquisition of gut-microbes may have enabled
a large fermentative platform to supply the host with essential
biomolecules (MacKie, 2002; Gill et al., 2006; Ley et al., 2008;
Conlon and Bird, 2014). Constantly shaped by its interaction with
the host, the human GI microbiota plausibly diverged from other
microbial communities found in nature (Thaiss et al., 2016a).
Consistent with this possibility, culture-free genetic profiling of
the 16S ribosomal (r) RNAs revealed major differences between
free-living, or non-animal-associated, microbial communities
and gut-associated microbiomes (Ley et al., 2008; Lagier et al.,
2016). The microbiota and the host co-evolve with each
other, albeit at different speed. Experiments in murine models
provide growing evidence of deep relationships between the GI
microbiota and the host physiology and gene expression (e.g.,
Stappenbeck et al., 2002; Round andMazmanian, 2009; Dalmasso
et al., 2011; Ghosh et al., 2011; Larsson et al., 2012; Reinhardt
et al., 2012; Thaiss et al., 2016a). The adult GI microbiota
was found to have a large inter-individual variation, with over
1,000 different bacterial species (Qin et al., 2010; Guinane et al.,
2013). Archaea (especially the genus Methanobrevibacter) and
fungi (phyla Ascomycota and Basidiomycota) also characterize
a large portion of the human GI microbiome (Hoffmann et al.,
2013). 16S rRNA analyses have revealed that more than 90%
of bacterial species found within the gut are Bacteroidetes and
Firmicutes, as well as Proteobacteria (Hold et al., 2002; Wang
et al., 2003; Qin et al., 2010; Guinane et al., 2013). Proteobacteria
and Bacteroidetes are Gram-negative bacteria involved in
carbohydrate digestion, gut microbiome development, immune
system modulation, and protection against colonization by
pathogens (Russell et al., 2014). Some Firmicutes are Gram-
positive bacteria that also digest carbohydrates (Berry, 2016).
Human-associated Archaea, among which Methanobrevibacter
smithii found in almost 96% of healthy subjects, synthesize
methane from H2 produced by bacterial catabolism (Hoffmann
et al., 2013; Lurie-Weinberger and Gophna, 2015). Human-
associated fungal species include Saccharomyces, Candida, and
Cladosporium, and several low-abundance strains (Hoffmann
et al., 2013). M. smithii, Saccharomyces, and Candida were
frequently found together in individuals having carbohydrate-
rich diets (Hoffmann et al., 2013). While Candida remains
asymptomatic in many individuals, immuno-suppression and/or
antibiotic treatment may promote outgrowth and niche specific
invasion throughout host tissues and mucosal sites (Huffnagle
and Noverr, 2013). The GI microbiota appears sustained through
complex interaction networks between the main phyla with
the observed microbial proportions, likely reflecting the range
of reciprocal exchanges needed for the dynamic physiological
balance of both microbiota and the host (Qin et al., 2010; Cho
and Blaser, 2012; Lagkouvardos et al., 2017). The GI microbiota
also appeared relatively resilient and stable (Faith et al., 2013;
Schloissnig et al., 2013) which seemed to suggest the possibility
of developing new biomarkers for diagnostics and possibly for
therapeutic purpose. Within single individuals, the environment
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changes along the GI tract, thus different microbes and
population densities are found in a continuum along the different
regions, reflecting their adaptation to distinct pH, enzymatic
conditions, anatomical structures, and physiology (Schneeman,
2002). For example, the pH in the mouth is close to neutral and
the saliva contains enzymes inhibiting bacterial growth, while the
stomach is extremely acidic (pH 2). The pH gradually increases
in the small intestine and the colon (pH 4–5 and 7 respectively,
Evans et al., 1988). Analyses of the human microbiome by the
Human Microbiome Project revealed that, besides the dominant
phyla, Bacteroidetes and Firmicutes, there was a great variation
in relative composition of the microbiota, both in phyla-genus
distributions, as well as individual differences that were initially
grouped into different enterotypes (HMPC, 2012a,b). In the
upper digestive tract stomach and small intestine, dwell abundant
aerobic and facultative anaerobic species, while in the lower
GI tract reside anaerobic species. In addition, functionally
redundant species were found in multiple niches of the GI tract
(Sommer and Bäckhed, 2013; Lozupone et al., 2012; Browne et al.,
2016). As studies were extended to more and more subjects it
became increasingly clear that individual variability was higher
than anticipated and there was a need to revise the enterotype
concept from one of fixed categories to one of a continuum along
multiple dimensions (Knights et al., 2014). Interestingly, re-
analyses of a sample time course from a single individual revealed
that the GI microbiome may change enterotype, presumably
indicating its adaptive capacity (ib.).
That no unique or discrete formula for a “healthy microbiota”
seems to exist may reflect microbial functional redundancy
enabling multiple species to play similar roles in the microbiota-
host relationship. Other factors may also contribute, such as
genetics and diet (Turnbaugh et al., 2007; Qin et al., 2010). In
the context of the relationship between host and microbiota it
seems advantageous that a healthy microbiota be able to carry
out certain metabolic functions, such as providing short chain
fatty acids (SCFA) to the intestinal epithelial cells. Metagenomic
analysis showed that gene functionality of healthy microbiota
appears indeed similar across individuals (HMPC, 2012b).
Recent metabolomics studies have also revealed diverse inter-
individual profiles that promise to yield biomarkers for various
diseased states (reviewed in Vernocchi et al., 2016). Relative
balance among different microbial groups seems important for
the host health and pathological alterations of such balance are
defined as dysbioses (Tamboli et al., 2004). Regardless of its
cause, dysbiosis correlated with various pathological conditions
of the host, such as Inflammatory Bowel Disease (IBD), Type
1 Diabetes, Rheumatoid Arthritis (RA), asthma and obesity
(reviewed in Keeney et al., 2014) and there is suggestive evidence
that the gut microbiota may also be implicated in cancer (Ray
and Kidane, 2016; Wroblewski et al., 2016; Yamamoto and
Matsumoto, 2016) and may at least influence certain mental
health conditions via the gut-brain axis (Moos et al., 2016; Mu
et al., 2016; Obata and Pachnis, 2016).
Because of its enormous surface separating digesting food
from the body and its role in nutrient absorption, the intestine
is a fundamental barrier for the integrity and health of the
organism, which is constantly patrolled by the immune system.
In its complex synergy with the host’s immune system, the
GI microbiota stimulates and is in turn stimulated by innate
immunity, a balance that can be altered by pathogens trying
to access the riches of the intestinal ecological niche (Thaiss
et al., 2016b). During infection innate immunity and the resident
microbiota cooperate to displace the pathogens actively via
antimicrobial molecules and passively by crowding the niche
and impeding the pathogen attachment to the gut lining.
Simultaneously, the host-microbiota preferential relationship is
promoted by secreted fucosylated molecules on the surface of
the intestinal epithelial cells that favor resident microbes (Pickard
et al., 2014).
We now realize the enormous impact the gut microbiota
has onto human health and it has become an intensely studied
subject, with a wealth of information being produced. This review
examines recent discoveries about the diverse relationships
between the human host and its microbiota from the perspective
of the biological interactions of mutualistic symbiosis and/or
commensalism between microorganisms and their human host
(Figure 1). As we discover the many nuances of these complex
connections and the underlying biomolecular associations, we
raise questions about the partners’ autonomy in the host-
microbiota relationship. The holobiont theory describes the host-
microbiota as a single biological unit, called the holobiont,
which functions dynamically and appears to be subjected to
evolution, rather than—or possibly in addition to—the individual
species composing it (Bordenstein and Theis, 2015). Despite their
poly-genomic composition, the deeply symbiotic relationships
that have persisted among hosts and microbes across many
groups and over time was used to define a consortium of
interactions suspected to be cohesive with respect to selection
processes (Booth, 2014; Bordenstein and Theis, 2015). Still
controversial, the concept of the hologenome (i.e., the gene
ensemble comprising a host and microbe syndicate) relies on
cooperative integrated features of the host-microbiome partners
with high fidelity of co-transmission, the latter being essential
for being subjected to selective pressure (Zilber-Rosenberg and
Rosenberg, 2008; Gilbert et al., 2012; Rosenberg and Zilber-
Rosenberg, 2013; Douglas and Werren, 2016). Appealing for
its inclusion of the functional relationships between host and
microbiota, the holobiome concept is difficult to apply in the case
of horizontally acquired symbionts, which do not have cohesive
genomes with respect to different individuals (Douglas and
Werren, 2016). Rare examples may include the endosymbiotic
acquisition of nuclear organelles, which would be, however, an
integrated part of a hologenome and not an entire microbiome
(Douglas and Werren, 2016). As such, the holobiont and
hologenome concepts have demonstrated poor research utility
(Douglas and Werren, 2016).
FUNCTIONS OF THE GI MICROBIOTA:
NUTRIENT PROCESSING AND
AVAILABILITY
The GI microbiota contributes to the host’s digestion by
making carbohydrates available (Stecher, 2013; Conlon and Bird,
2014). Among the resident bacteria, species belonging to the
phyla Bacteriodetes and Firmicutes can ferment undigestible
carbohydrates, the fiber, to produce short chain fatty acids
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FIGURE 1 | Factors affecting the human GI microbiota and host functions affected, either directly or indirectly, by the GI microbiota.
(SCFAs), branched fatty acids, lactate, ethanol, CO2, and H2
which are then utilized by secondary fermenters, by the host,
or excreted (Cummings et al., 1989; Belenguer et al., 2006; Flint
et al., 2008; Fischbach and Sonnenburg, 2011; Sheridan et al.,
2016; Patrascu et al., 2017). Of note, microbiota-produced SCFA
constitute the main energy source of the intestinal epithelial cells
(Topping and Clifton, 2001; Louis et al., 2010). Bacteria in the
human gut microbiota can also synthesize beneficial vitamins
such as folate, biotin, and vitamin K (Cummings andMacFarlane,
1997) and neutralize potentially carcinogenic compounds such
as pyrolysates (Morotomi and Mutai, 1986). Gut bacteria
detect available polysaccharides and activate different metabolic
utilization pathways. In the case of the well-studied Bacteroidetes
and the Firmicutes family Lachnospiraceae, these enzymes are
encoded by multiple polysaccharide utilization loci (PULs,
Bjursell et al., 2006; Martens et al., 2011; Sheridan et al., 2016)
conferring the ability to utilize different glycans as carbon
sources, which may allow trophic diversification, moderate
species competition and facilitate distal gut colonization (Bjursell
et al., 2006; Martens et al., 2011; Sheridan et al., 2016).
The GI lumen, with its over 200 grams of digested contents,
provides a diverse and competitive microbial environment for
both mutualistic and pathogenic microorganisms. Successful
colonization of a species acquired from the environment may
depend on the ability to utilize differential nutrient sources,
perform chemical sensing, and coordinate gene expression in
favorable ways (Lozupone et al., 2008; Pacheco et al., 2012;
Patrascu et al., 2017). Moreover, the presence of “keystone
species” with rare metabolic capabilities may generate energy and
cross-feed other microbial community members (Ze et al., 2012,
2013). Host genetics, food availability, dietary modifications,
and resident microbes will influence contents and environment
of the GI tract, conceivably affecting each microbial species
differentially, and potentially shaping both species representation
and numerical abundance of the community members. These
models seem to agree with the results of both observational
studies that correlated diet with microbiota composition in
individuals from different geographical locations (De Filippo
et al., 2010; Yatsuneko et al., 2012; Schnorr et al., 2014)
and of human studies employing controlled diets (Walker
et al., 2011; Martinez et al., 2013; David et al., 2014; O’Keefe
et al., 2015). Because of the impossibility to experimentally
control variables such as the individuals’ different genetic
makeup and individual microbiota composition, the conservative
interpretation is that the microbiota was found to respond to
dietary changes quickly, with some microbial communities more
readily responding to such changes than others (Walker et al.,
2011; Salonen et al., 2014). These dynamics are reminiscent
of other microbial expansions in natural habitats (e.g., algal
blooms) where excess of certain nutrients may favor the over-
proliferation of definite groups and outcompete other species in
the same environment, reducing overall microbial diversity, and
highlighting the potential to adapt ecological models for studying
the GI microbiota.
Because of its dynamic nature, the microbiota could
potentially be manipulated via dietary changes and
administration of either antibiotics or probiotics to, respectively,
increase or decrease microbial numbers and diversity. Probiotics
can be aliments such as traditional fermented foods rich
in live microorganisms (e.g., sauerkraut, kimchi, yogurt) or
supplements (Voreades et al., 2014; Zuk, 2014) which have
been used to promote proliferation of beneficial microbes
and organismal diversity at the expense of selected pathogens
in diseases accompanied by dysbiosis (Saxelin et al., 2010).
Prebiotics on the other hand, provide molecules to stimulate
and support resident GI tract bacteria (Bouhnik et al., 2004,
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2006; Ramirez-Farias et al., 2009; Davis et al., 2011; Dewulf
et al., 2013). Probiotic administration was found to increase gut
microbial diversity in obese patients up to a month (Kadooka
et al., 2010; Wassenaar et al., 2014) suggesting the feasibility of
directing changes in the microbial imbalance of the GI tract by
outcompeting harmful bacteria (Rigottier-Gois et al., 2015). A
stimulating prospect, GI microbiota manipulation reminds us
that our incomplete knowledge of the GI microbiota ecology and
its intricate relationships with the host may result in accidentally
favoring opportunistic pathogens or provoking pathological
responses (Mukherjee et al., 2013). On the other hand, microbial
competition could in principle be employed strategically to limit
or eliminate pathogens in alternative to conventional antibiotic
treatments, with the added advantage of preventing horizontal
transfer of antibiotic resistance genes.
IMMUNITY AND GI MICROBIOTA
Early development of the gut microbiota has been shown to
be important for normal immune response and to prevent
autoimmune disease (Round andMazmanian, 2009). Because the
relationship between host immune system and microbiota has
been recently reviewed thoroughly (Belkaid and Harrison, 2017)
and most of our co-authors had not yet studied Immunology,
a fourth year course, here we will just recall a few concepts
for completeness and refer interested readers to Belkaid and
Harrison. The GI microbiota is essential for the maturation of
the immune system, which is composed by both adaptive and
innate immune responses. Innate immunity relies on the physical
barrier of the epithelia, circulating chemicals and specialized
cells to quickly recognize a broad range of foreign antigens
on cells with pathogenic potential and eradicate them (Reece
et al., 2011; Lupfer et al., 2014). On the other hand, adaptive
immunity deals with pathogens through a slower, albeit long-
lasting, response via stimulation of lymphocytes expressing
specific cross-reactive antibodies (Lupfer et al., 2014). Displaying
the largest density of epithelial cells (EC) in the body, the
GI tract receives more antigens than any other body parts
through ingested foods and the interactions with the microbiota
(Kuhn et al., 2014; Shi et al., 2017). The latter contributes
to maintenance of the intestinal barrier at various levels. For
example, it stimulates the goblet cells to produce the mucus
lining the intestine (Kandori et al., 1996); it is involved in
determining the specificity of the luminal immunoglobulins A,
which recognize antigens in potential pathogens (Brandtzaeg
et al., 2006) and contrasts their adhesion for effective clearance
(Johansen et al., 1999; MacPherson and Uhr, 2004). Because
every microorganism in the gut, both commensal and foreign,
can (and will) be targeted by the host’s immune system, it may
seem surprising that healthy interactions between the specialized
intestinal phagocytic macrophages and the microbiota normally
do not cause release of pro-inflammatory cytokines IL-1 and TNF
and inflammation (Smythies et al., 2005). How host immunity
avoids being overpowered is only partly known and actively
being investigated. Because of the high selectivity of the gut
environment, only microbes able to establish a “dialog” with
the host can colonize the microbiota, while the others will
be eliminated by the combined action of the host’s immunity
and the resident microbes, some of which can synthesize
bacteriocins which actively target competing species (Corr et al.,
2007; Hibbing et al., 2010; Patwa et al., 2011; Dobson et al.,
2012). Interestingly, germ-free mice were found to contain fewer
circulating lymphocytes (Wostmann et al., 1970) suggesting that
GI microbes may also affect adaptive immunity.
NUTRIENTS, BACTERIAL COMPETITION,
AND COLONIZATION
The mammalian gut environment is fairly protected and has
relatively stable temperature, yet it is dynamic and competitive,
imposing a strong evolutionary pressure onto the microbes.
The resident microbiota is constantly sensing and integrating
information on nutrients and microbial content of digested
food and drinks, the glycans projecting from the surface of
intestinal cells, and the overall health and immunity of the host.
The tight interaction web between host and its GI microbiota
allows resident microbial communities to monopolize nutrients
and adhesion sites and establish a molecular and genetic
“dialog” with the host, simultaneously blocking newcomer,
potentially pathogenic, microorganisms from accessing the high
energy sources they need to replicate and establish themselves
in the community (Stecher, 2013). To successfully colonize
the intestine, microorganisms must withstand fast changes
in nutrients, high osmolarity and stomach acidity, bile salts,
protective mucus, and microbial competition. Antigens detected
in unfamiliar bacteria cause phagocytosis from the host’s cells.
Bacteria that can avoid phagocytosis can begin colonization by
proliferating initially in small niches. These localized microbial
blooms may cause resource competition and transiently alter gut
ecology, although the long-term outcome of the inter- and intra-
specific bacterial competition allowing the stable colonization
of the new species or its demise likely depends on the context
of resource availability, interactions with the microbial species
in the same trophic level as well as the host’s immunity (de
Muinck et al., 2013). Large scale bacterial invasions, as may result
from the ingestion of contaminated food or water, may severely
compromise the resident microbiota, reducing its diversity in
favor of the expansion of selected strains.
The host’s nutritional status may affect both microbiota
diversity and microbial colonization. How well strains can adapt
and access nutritional resources can contribute to reproductive
success of both resident microbes and foreign invading species.
Upon introduction into the mammalian gut, Escherichia coli and
other Gram-negative bacteria were observed to undergo many
rounds of mutation, producing both adaptive and deleterious
variants that spread through the population simultaneously in
so called “soft sweeps” (Barroso-Batista et al., 2014). Should any
mutation provide survival advantage (or possibly by chance in
small populations) it could become established and compete
with all others for fixation. In a germ-free mouse model
that recapitulates and simplifies the complexity of the natural
ecological conditions, inoculation of model E. coli strain MG
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1655 showed the appearance of the first beneficial mutation just
2 days after invasion, which lead to quick adaptation to the
murine host. MG1655 carried loss of function mutations in the
gat and srl operons (which encode the biochemical machinery
for utilizing galactidol and sorbitol respectively) enabling the
mutants to utilize alternate carbon sources in conditions of
high competition for nutrients (ib.). Another adaptive mutation
in the arcA gene critically enabled switching between aerobic
and anaerobic respiration depending on oxygen levels (ib.).
In this system, the temporal unfolding of the colonization
process appeared influenced by strong selection as well as the
contributions of multiple small effect mutations in a process that
could surprisingly be repeated, which may intriguingly suggest
the existence of predictable driving forces (Lourenço et al., 2016).
The capacity of utilizing ready-made metabolic intermediates
may also be advantageous for microbes. Vitamin B12 is a cofactor
required for metabolic processes in over 70% of Gram-negative
bacteria whose de novo synthesis requires 30 steps. Combinations
of metabolically economic systems of transmembrane “corrinoid
receptors” for absorbing B12 itself or its analogs (collectively
termed corrinoids) have been found in many species and
appeared to increase the cell’s fitness, depending on corrinoid
availability (Degnan et al., 2014; Sonnenburg and Sonnenburg,
2014).
Besides mutations affecting nutrient uptake and utilization,
mutations in genes with regulatory functions may also provide
means of fine-tuning adaptation by affecting downstream
pathways both additively and independently (Giraud et al., 2008).
While phenotypic variants compete for survival and dominance
within the same trophic level, both ecological context (e.g.,
other microbial species in the same trophic level, host genetics)
and environmental resource availability may result in different
colonization patterns dynamically and over time. Ex vivo studies
of simplified models of GI microbiota found that, during the
early colonization stages, both aerobic and facultative anaerobic
E. coli strains could thrive until oxygen reserves were exhausted
and obligate anaerobes strains took over (de Muinck et al.,
2013). However, introduction of other bacterial species was
found to change the outcome: Clostridium perfringens, naturally
present in the gut microbiota, lowered environmental peptone
levels, impairing the success of the anaerobes, which were
more dependent on peptone than the aerobic strains (ib.). Host
immunity appears to contribute to colonization. Considering
the microbiota diversity in vivo, we expect that the microbial
interaction web will be at least as complex as what has been
observed in other environmental poly-microbial communities,
with the added component of multiple layers of interaction
with the host. In the context of this formidable, yet fascinating
complexity, studies of murine models may not fully reproduce
the species-specific interactions of the human microbiota with
the human host (Chung et al., 2012; Du et al., 2015) yet may
provide controlled experimental conditions in which genetic
homogeneity and germ-free culturing conditions minimize the
influence of compounding factors such as inflammation, thus
facilitating the study of the molecular mechanisms of interaction
between the host and either single species or controlled microbial
mixtures (e.g., the simplified human microbiota, Becker et al.,
2011; Eun et al., 2014), whose knowledge contributes to our
global understanding of the host-microbiota relationship.
NUTRIENT NICHES FAVORING
PATHOGENIC GUT COLONIZATION
Resource acquisition is crucial for microbes (including
pathogens) aiming at colonizing the competitive environment
of the mammalian intestine and these species must overcome
the inherent colonization resistance of healthy individuals (Van
der Waaij et al., 1971; Faust et al., 2015). In healthy individuals
competition for both nutrients and attachment sites make
pathogens such as Clostridium difficile less likely to colonize the
gut and become a burden to the host (Guarner and Malagelada,
2003). The enterohaemorrhagic E. coli strain O157:H7 found
in undercooked meat and contaminated produce is responsible
for many bacterial food poisoning cases in developed nations
(Loftsdóttir et al., 2017). What makes O157:H57 successful
is its ability to regulate gene expression in response to its
surroundings. Commensal E. coli are found in the mucus layer,
whereas O157:H57, along with non-pathogenic Bacteroides
thetaiotaomicron, are found on the intestinal epithelium (Iversen
et al., 2015). Rather than counterproductively competing for
resources in the mucus layer, O157:H57 can colonize areas of
high fucose availability on the intestinal EC (Pacheco et al.,
2012). B. thetaiotaomicron cleaves fucose from host produced
mucin, which activates the FusKR receptor in O157:H57 and the
expression of virulence factors. Upon successful colonization of
the intestinal epithelium, O157:H57 metabolizes carbon sources
such as galactose, which are not being utilized by commensal
E. coli.
Campylobacter jejuni, typically acquired through ingestion of
uncooked poultry, causes a form of human gastroenteritis (Olson
et al., 2008). A highly fermentative healthy microbiota generates
steady supplies of organic acids such as acetate and lactate
that constitute electron and carbon sources for downstream
metabolism. C. jejuni was found to contain two completely
redundant respiratory enzyme systems for growth on L-lactate,
underscoring the evolutionary advantage of being able to grow
on lactate (Thomas et al., 2011).
One of the best characterized examples of pathogenic bacterial
infection is that of the members of the Salmonella genus, that
utilize an arsenal of resources during their attempts at gut
colonization. Salmonella enterica serovar Typhimurium (hereby
referred to as S. Typhimurium) is a common Gram-negative
microorganism of the Enterobacteriaceae family that causes
typhoid fever and food poisoning. All Salmonella serotypes are
disease causing in humans, but only certain ones are host specific
(WHO, 2016). The dominant strain responsible for human
pathogenicity is S. typhi, while S. Typhimurium, also pathogenic,
is transmitted from animals to humans either directly or via
contact or consumption of undercooked infected meat (WHO,
2016). In the initial phase of invasion, S. Typhimurium generates
energy via the hyb hydrogenase-mediated oxidation of H2, a
readily available by-product of resident microbe metabolism
(Lamichhane-Khadka et al., 2010; Maier et al., 2013, 2014).
Frontiers in Microbiology | www.frontiersin.org 6 July 2017 | Volume 8 | Article 1265
Selber-Hnatiw et al. Gut Ecology
Because hyb mutants displayed impaired growth, hyb function
appears necessary for invasion. Moreover, H2 sequestration
by an avirulent strain able to utilize H2, S. Typhimuriumavir,
could thwart S. Typhimurium colonization (Maier et al., 2013).
Energetic strategies based on H2 utilization are also employed
by other pathogens to gain purchase on the resident microbiota,
among which Campylobacter, Shigella, and Yersinia (ib.). When
nutrients are scarce, many bacteria become more motile as
they forage for survival. Distinctively, nutrient abundance was
found to stimulate a bistable response in S. Typhimurium
in which a proportion of cells activated the expression of
flagellar proteins becoming highly motile and continuing host
invasion. The other cells, instead, remained non-motile and non-
invasive, bypassed the host’s inflammatory response and may
fuel subsequent colonization bouts (Koirala et al., 2014). To
gain advantage on the commensal species of the microbiota, S.
enterica can release colicin Col1b, a pore-forming toxin targeting
the Enterobacteriaceae family and especially E. coli (Nedialkova
et al., 2014). Because toxin synthesis is energetically expensive
and Col1b is toxic to Salmonella itself, only few cells in the
population were found to secrete colicin (ib.). Interestingly,
the success of a colicin invasion strategy may depend in part
on nutrient availability, because the presence of iron caused
conformational changes of the E. coli receptor, reducing its
sensitivity to Col1b (Pugsley and Reeves, 1976). Finally, S.
enterica can form biofilms, robust bacterial sheets protected by a
self-secreted polysaccharide matrix which can adhere to surfaces.
Albeit likely to occur, we do not have experimental evidence
of biofilm formation in vivo. If confirmed, such capacity may
conceivably contribute to colonization (Chelvam et al., 2014).
The capacity for Salmonella biofilm formation is encoded on
several different plasmids, one being pRST98, whose expression is
triggered by extracellular signaling molecules N-acylhomoserine
lactones, which are part of the quorum sensing system activated
by bacteria in crowded populations (Liu et al., 2014).
MICROBIOTA MANIPULATION OF HOST’S
BEHAVIOR?
While commensal GI microorganisms can extract nutrients from
the food, they do require specific nutrients to thrive. During
studies on the causative factors of obesity it was observed that
the GI microbiota may modulate expression of taste receptors
(Miras and le Roux, 2013; Avau et al., 2015; Avau andDepoortere,
2015; Murtaza et al., 2017), affect the vagus nerve which controls
the gut-brain axis (Rhee et al., 2009; Bercik et al., 2012; Collins
et al., 2012; Vaughn et al., 2017) and influence the release of
toxins and neuro-transmitters (Kollai et al., 1994; Lyte et al.,
2011; Clarke et al., 2014). In a small human study, probiotics
were found to stimulate both number and diversity of gut
microbiota in obese adults and reduced host cravings, raising
the untested possibility that the subjects’ eating preferences may
have been modified (Kadooka et al., 2010). Initial attempts at
probing this possibility in mice made use of either probiotics or
antibiotics administration to alter the GI microbiota and observe
changes in the hosts’ eating patterns and food preferences, which
appeared to correlate with the nutritional requirements of the
current resident microbes (Alcock et al., 2014; Zuk, 2014). The
ratio of Bacteroidetes to Firmicutes is often used as an indicator
for body mass, with high ratio observed in lean individuals
and low ratio in obese ones respectively (Bäckhed et al., 2004;
Ley et al., 2005; Turnbaugh et al., 2006, 2007; Zhang et al.,
2012; Evans et al., 2014; Lecomte et al., 2015; Shang et al.,
2017). The Firmicute family Lachnospiraceae is responsible for
producing SCFAs that can fuel the growth of other gut microbes
and host epithelial cells, and may enhance the host’s energy
harvesting capacity, resulting in liver lipogenesis and triglyceride
accumulation (Meehan and Beiko, 2014; Singh et al., 2015; Nehra
et al., 2016; Shang et al., 2017). Consumption of certain food
groups seemed to affect both the Bacteroidetes to Firmicutes
ratio and the diversity in the gut, which in turn may influence
the gut-brain vagal communication, potentially contributing to
obesity (de la Serre et al., 2015; Sen et al., 2017). These intriguing
results suggest that the microbiota may influence the host’s eating
preferences affecting its mood and satisfaction for certain food
groups, possibly depending on the nutritional requirements of
the members of the microbial community. Only supported by
correlative evidence, this speculative scenario raises interesting
points of reflection. Considering that each microorganism in the
microbiota could potentially and competitively manipulate the
host for its own benefit, a diverse microbiota would favor the
host by lessening the intensity of the influence by any single
microbial group. Conversely, a microbiota composed of fewer,
more numerous groupsmay potentially exert a stronger influence
on host eating behavior (Alcock et al., 2014), which would agree
with the peculiar microbiota composition observed in certain
eating disorders.
THE MICROBIOTA IN FASTING AND
MALNUTRITION
Dynamically responding to environmental conditions, the
microbiome responds to nutritional changes, including fasting
and malnutrition (Arumugam et al., 2011; Flint et al., 2014).
Because of ethical reasons the effects of starvation on the GI
microbiota has only been studied in controlled settings in animal
models. Several weeks of nutrient deprivation in fish, mice and
toads displayed increased microbiome diversity; quails showed
no change, and geckos a decrease (Kohl et al., 2014). Seasonal
fasting can occur naturally, e.g., during molting of king and
small penguins, when energy reserves whose deposition depends
on gut function become essential for thermoregulation and
producing new plumage. Molting penguins exhibited changes in
microbiota composition, especially after prolonged fasting. King
penguins displayed increased Proteobacteria during early molt,
and decrease of both Proteobacteria and Bacteroidetes during late
molt (Dewar et al., 2014). Conversely, in hibernating squirrels
the normally dominant Firmicutes group contracted throughout
hibernation. A small, representative bacterial population seeded
the rebound of gut microbiota during the active months (Dill-
Mcfarland et al., 2014). These variable responses to starvation
make it difficult to model the effects of nutrient deprivation
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in humans, which we can only observe in specific cases of
malnourished individuals. Human moderate and severe acute
malnutrition are significant global health issues. Respectively
affecting ∼19% of children in Asia and 20 million children
globally (WHO, 2007), they are leading causes of child mortality
(Smith et al., 2013). Severe malnutrition is typically treated with
nutrient-rich “ready-to-use therapeutic food,” which reduces
mortality, albeit children cannot fully recover even after
body mass improvements, likely because of their immature
microbiomes (Prentice et al., 2013; Tilg and Moschen, 2013;
Subramanian et al., 2014). In fact, early gut microbiome
development is particularly important in children, whose
microbiota shifts as they grow and change diet (Bergstrom et al.,
2014). Microbiota remodeling by antibiotic therapy improved
survival of children with severe acute malnutrition (Trehan et al.,
2013; Subramanian et al., 2014), however when the microbiome
remained immature severe malnutrition re-occurred, suggesting
that microbiome maturity may predict the long-term success of
therapeutic food administration (ib.). Moreover, the enterotype
appeared to contribute to the onset of severe malnutrition, an
effect that could be reproduced by transplanting the human
GI microbiota into gnotobiotic mice (Smith et al., 2013).
Although current studies on human malnutrition are only
observational, there are hopes that therapeutic remodeling of
the GI microbiota may help eliminate malnutrition-associated
mortality.
MAINTAINING THE GI MICROBIOTA
DURING ACUTE INFECTIONS
During the host’s response to pathogenic microorganisms
initial anorexia can starve the pathogen while the host utilizes
its own resources for resisting infection (Langhans, 2000).
Anorexia could in principle also starve the microbiota; however,
sophisticated preferential communication between the host and
its microbiota was found to support the resident microbes
during infection-induced stress. Lipopolysaccharides from the
bacterial cell wall interact with and activate Toll-like receptors
(TLRs) expressed on the membrane of intestinal macrophages.
In mice TLR activation activated interleukin release and the
fucosyltransferase 2 enzyme (Fut2) in the small intestine
epithelial cells, resulting in fucosylation of certain membrane
proteins (Pickard et al., 2014). Superficial L-fucose can be
preferentially cleaved and utilized by the resident microbes
(ib.). It was observed that Fut2 polymorphisms may confer
susceptibility to Crohn’s Disease (Rausch et al., 2011) and its
mutation both reduced microbiota diversity (Patwa et al., 2011;
Wacklin et al., 2011) and increased sensitivity toCandida albicans
infections in mice (Hurd and Domino, 2004). Contrary to initial
reports, the bacteria-host interaction was found to be insufficient,
albeit necessary, to trigger fucosylation in intestinal epithelial
cells (Goto et al., 2014). Two additional mechanisms were found
to contribute to fucosylation, the first being mediated by the type
3 innate lymphoid cells residing in the mucosal lining, which
produce interleukin-22 in response to the resident microbiota
and induce Fut2 (ib). Reinforcing such mechanism, interleukin-
22 also induces expression of the antibacterial RegIII-γ molecule
(Satoh-Takayama et al., 2008; Sonnenberg et al., 2011; Tumanov
et al., 2011). Finally, lymphotoxin α, also secreted by ILC3, could
induce fucosylation independently of the microbiota (Patwa
et al., 2011; Goto et al., 2014).
PATHOLOGIES WITH ALTERED GI
MICROBIOME
Because the GI microbiota interacts with the host immunity
at multiple levels, dysbiosis may result in or be indicative of
pathologies (Table 1). In fact, because of the complexity and
reciprocity of the microbiota-host relationships it is debated
whether the dysbiotic state may cause or be consequence of
the pathology (Butto and Haller, 2016). Alterations of the
composition of the GI microbiota may occur upon exposure to
antibiotics, drugs, or radiation (Wallace et al., 2011; Nam et al.,
2013; Keeney et al., 2014), stress or infections (Moloney et al.,
2014), and nutritional changes (Griffin et al., 2017). Asthma
and inflammatory bowel diseases (IBD) were both found to be
directly affected by the interactions between the gut microbiota
and host immunity.
Asthma
Asthma is a chronic disease that causes inflammation of the
airways (NIH, 2014). In asthma, both low diversity and a
numerically reduced gut microbiota eventually appears to induce
allergy and lung hypersensitivity (Table 1, Ferreira et al., 2014).
Common symptoms include wheezing, coughing, difficulty
breathing, or shortness of breath with variable severity. It
has been proposed that asthma prevalence may be increasing
in Western countries because of lifestyle modifications that
impoverish the microbiota, including excessive hygiene, liberal
use of antibiotics and a high-fat diet (Strachan, 1989; Wills-
Karp et al., 2001; Vercelli, 2009, 2010; Von Mutius and Vercelli,
2010; Allan and Devereux, 2011; Korpela et al., 2016). However,
research is still developing about the long term effects of
antibiotic use on the microbiota (WHO, 2014; Korpela et al.,
2016). Epidemiological studies indicated that early life exposure
to microbes helps preventing allergic diseases, leading to the
“hygiene hypothesis” (Wills-Karp et al., 2001). This theory
speculates that reduced microbial exposure due to aggressive
cleaning, disinfection, urbanization, and impoverished diets may
lead to altered microbiota and inadequate immune function
(Ferreira et al., 2014). The findings of Weber et al. (2015) suggest
that home or personal cleanliness may in fact have no impact
on the development of asthma. Rather, a variety of microbial
exposures may determine microbiota composition, possibly
leading to the development of asthma in predisposed individuals
(Ege et al., 2011, 2012; Weber et al., 2015). Asthmatic children
were found to have prevalence of the pathogenic C. difficile
and low abundance of non-pathogenic Bifidobacterium in their
intestinal microbiota, which may reduce immune function in the
airways (Kalliomäki et al., 2001a,b) and potentially contribute to
disease chronicization.
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TABLE 1 | Diseases associated with GI microbiota abnormalities.
Disease Features References
Rheumatoid arthritis Chronic, inflammatory auto-immune disorder displaying reduced Bifidiobacteria
and Bacteroidetes-Porphyromonas-Prevotella group, Bacteroidetes fragilis
subgroup, and Eubacterium rectale-Clostridium coccoides group, and increased
Lactobacillus.
Wu et al., 2016
Inflammatory bowel disease Dysbiotic inflammatory response to intestinal microbes. Increased numbers of
innate immunity cells (neutrophils, macrophages, dendritic cells, and natural killer
T cells) and adaptive immunity cells (B and T lymphocytes), which enact immune
tolerance or defense against the intestinal microbiota.
Abraham and Cho, 2009; Halfvarson et al., 2016
Irritable bowel syndrome Enrichment of Firmicutes and reduction of Bacteroidetes. Krogius-Kurikka et al., 2009; Rajilic´-Stojanovic´ et al.,
2011; Jeffery et al., 2012; Kennedy et al., 2014
Ulcerative colitis Reduction of Bifidobacteria. Inflammation confined to the mucosa of the colon. Abraham and Cho, 2009; Duranti et al., 2016
Crohn’s disease Reduction of Firmicutes and Bacteroidetes. Transmural inflammation. Eckburg and Relman, 2007; Abraham and Cho,
2009
Ileal Crohn’s disease A form of Crohn’s disease typified by decreased Paneth cell α-defensins,
weakened antibacterial activity of the ileal mucosa, leading to bacterial
composition changes in the microbiota.
Wehkamp et al., 2005
Type 1 diabetes Auto-immunity against pancreatic β-cells (normally producing insulin) in
genetically predisposed individuals. Defective development or alterations of the
microbiota may result in dysregulated immunity with autoimmune β-cells
destruction, and/or increased leakiness of the gut epithelial barrier. Decreased
microbiome diversity.
Atkinson and Eisenbarth, 2001; Bosi et al., 2006;
Vaarala et al., 2008; Atkinson et al., 2013; Dunne
et al., 2014
Asthma The airway microbiome is affected by outbreaks of Chlamydophila pneumoniae
during the development of bronchitis and pneumonia. The GI microbiota is
affected by the environmental exposure of microbes, especially early in life, which
in turn affects the maturation of immune function to protect against allergic
sensitization.
Hahn et al., 1991; Huang and Boushey, 2015
Obesity Shift in the proportion of Firmicutes and Bacteroidetes with a significant increase
of the former, leading to obesity in conjunction with poor diet.
Consortium THMP, 2012; John and Mullin, 2016
Obesity and gastric bypass Significantly fewer Firmicutes compared to obese and healthy patients. Increase
in Gammaproteobacteria in post-gastric-bypass patients.
Zhang et al., 2009
Cancer (various) Carcinogenesis may develop in response to epithelial injury and inflammation
from infectious agents, genetic mechanism, or pathogens (e.g., Helicobacter
pylori, Salmonella enterica, Borrelia burgdorferi, Chlamydia psittaci).
Virchow, 1863; Balkwill and Mantovani, 2001;
Grivennikov et al., 2010; Moore and Chang, 2010;
Trinchieri, 2012; Schwabe and Jobin, 2013
Typhoid fever Caused by infection of Salmonella species (spp.) S. enterica serovar Typhi
(S. Typhi).
Rabsch et al., 2001; Crump and Mintz, 2010;
Graham, 2010; Ahmer and Gunn, 2011
Food poisoning and foodborne
pathogens
Opportunistic pathogens (e.g., Campylobacter, Salmonella, E. coli, Shigella,
Cronobacter, Listeria, Cryptosporidium, MRSA, etc.) disrupt the equilibrium of
the microbiome leading to dysbiosis, loss of host bacterial diversity and multiple
diseases.
Brown et al., 2012; Shim, 2013; Carriere et al.,
2015; Josephs-Spaulding et al., 2016
Malnutrition Decrease or absence of species that either efficiently process food categories or
produce vitamins may lead to reduced nutrient absorption and inflammation.
Enterobacteriaceae overgrowth may result in epithelial damage, diarrhea, and
reduced nutrient absorption.
Mohan et al., 2006; Lupp et al., 2007; Round and
Mazmanian, 2009; Kane et al., 2015
Clostridium difficile Infection A nosocomial pathogen, CDI is associated with epithelial inflammation and
necrosis of the colon, diarrhea, pseudomembranous colitis and toxic
megacolon. Antibiotic exposure may increase risk of re-infection.
Heinlen and Ballard, 2010; Khanna et al., 2016
Peptic ulcer disease Helicobacter pylori are H2- receptor antagonists responsible for peptic ulcers,
found in the stomach or duodenum. H. pylori was found to modify epithelial
proliferation and apoptosis in gastric mucosa, reducing proliferation and
increasing apoptosis in vitro in models of H. pylori infection.
Ding et al., 2008; Prabhu and Shivani, 2014
Chronic gastritis H. pylori infection shown to increase epithelial cell turnover rate in gastric
mucosa, with increased proliferation and apoptosis rates.
Wagner et al., 1997; Ahmed et al., 2000; Jang and
Kim, 2000; Choi et al., 2003; Suzuki et al., 2004;
Ernst et al., 2006; Ding et al., 2008
Gastric Mucosa-associated
lymphoid tissue (MALT) tumors
Associated with H. pylori infections. Microbial virulence factors (e.g., CagA, and
VacA) activate inflammatory processes and cell proliferation.
Fox and Wang, 2007; Francescone et al., 2014;
Wang et al., 2014
Multiple sclerosis Increased Methanobrevibacter (phylum Euryarchaeota) and Akkermansia
(phylum Verrucomicrobia) and decreased Butyricimoas (phylum Bacteroidetes).
Jangi et al., 2015
(Continued)
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TABLE 1 | Continued
Disease Features References
Depression Bifidobacterium infantis, normally found in GI of neonatal infants and in
administered probiotic drugs may have antidepressant effects in
psychobiological systems.
Desbonnet et al., 2010; Dinan et al., 2013; Evrensel
and Ceylan, 2015
Anxiety Oral administration of subclinical doses of Campylobacter jejuni in murine
models induced anxiety-like behavior without stimulating immunity. Lactobacillus
and Bifidiobacterium may function as anxiolytic influence in a murine model.
Sudo, 2006; Lyte et al., 1998; Bravo et al., 2011;
Messaoudi et al., 2011; Barrett et al., 2012;
Evrensel and Ceylan, 2015; Akkasheh et al., 2016;
Schnorr and Bachner, 2016
Non alcoholic fatty liver disease Reduced levels of Bacteroidaceae, Bacteroides and Oscillospira Chierico et al., 2016
Diarrheal illness Enteric infection of the jejunum caused by Cyclospora cayetanensis, a
foodborne and waterborne parasite. Results in diarrhea, including what is
referred to as traveler’s diarrhea.
Ortega and Sanchez, 2010
Giardiasis Infection of the protozoan Giardia lamblia transmitted through the consumption
of contaminated drinking water inducing abdominal cramps, gas, nausea, and
weight loss. In a murine model, Giardia colonization and proliferation affected
commensal bacteria with decreased Firmicutes and Melainabacteria, and
increased Proteobacteria.
Maloney et al., 2015; Barash et al., 2017
Invariant natural killer T cells (iNKT cells) are part of innate
immunity and mediate inflammation via interleukins IL-4 and
IL-2. In a murine asthma model, germ-free mice were found
to have higher counts of iNKT cells, compared to specific
pathogen free mice (Ferreira et al., 2014). In contrast, germ-
free mice colonized with normal mice microbiota appeared
protected from the inflammatory effects of accumulated iNKT
cells and from asthma (ib.). Interestingly, this was true only
if gut colonization occurred in newborns, supporting the idea
that early life microbial exposure may promote immune system
proficiency and potentially offer disease protection later in
life (Ferreira et al., 2014). Similarly, neonatal introduction of
Lactobacillus rhamnosus GG, a probiotic strain of human origin,
reduced allergic responses in the airways (ib.). L. rhamnosus
was found to induce macrophages and to moderately activate
the inflammasomes, cytoplasmic complexes responsible for
the regulation of the pro-inflammatory response and induce
macrophages (Martinon et al., 2009). Interestingly L. rhamnosus
exposure was also found to cross-protect the mice from
influenza A viral infection (Miettinen et al., 2012). Underscoring
the complexity of host-microbe interactions, comparison of
the global gene activation patterns elicited by the related L.
rhamnosus GG and LC705 strains revealed that, despite their
high degree of genetic relatedness, the two strains provoked
distinct responses in the host and displayed different levels of
gene activation with the induction of distinct gene sets (ib.).
Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is an aggravating long-
term inflammation of the intestine in which the commensal
microbiota plays a key role in conjunction with individual
genetic susceptibility (Elson et al., 2005; Obermeier et al., 2005;
Schirbel and Fiocchi, 2010; Ferreira et al., 2014; Liu et al., 2015).
IBD patients suffer intermittent severe bowel inflammation
and displayed distinct composition of the gut microbiota, with
decreased Firmicutes (Table 1, Walker et al., 2010; Ferreira et al.,
2014). Abnormal GI microbiota has also been observed in subsets
of patients affected by Crohn’s disease and ulcerative colitis,
two IBD variants (Park et al., 2017). Compared to healthy
controls, the GI microbiota of IBD patients displayed fewer
bacteria with anti-inflammatory properties and/or more bacteria
with pro-inflammatory properties (Ott, 2004; Ferreira et al.,
2014; Park et al., 2017). Inflammasome activation in the gut
triggered a cascade culminating in release of interleukins IL-
1β and IL-18, which in turn stimulated the inflammasome
and amplified the inflammatory response (Miettinen et al.,
2012). Corroborating a causal link between GI microbiota
and IBD, the resident bacteria in the GI tract were found to
prevent or alleviate IBD in murine models (Ferreira et al.,
2014). Germ-free mice were prone to developing colitis and
Crohn’s disease, while gut re-colonization following gavage
with healthy microbiota decreased inflammation (ib.). Early
observations indicated that IBD patients displayed damaged
intestinal barrier and increased intestinal permeability allowing
microbe translocation and activation of the systemic immunity
(Hollander et al., 1986). Translocation is a mechanism by which
microbes can break through the gut barrier, enter the circulation
and may reach other organs, unless targeted by innate and
adaptive immunity. Revealing a degree of functional overlap,
the gut microbiota was found to prevent translocation of the
probiotic E. coli strain Nissle 1917 even if either the adaptive
or innate immune system were to be defective (Gronbach
et al., 2010). Conversely, in the absence of a GI microbiota
the host’s immunity could prevent microbial translocation (ib.).
IBD susceptibility appeared to be linked to multiple defects
affecting the gut barrier, Paneth cells, and innate immunity that
result in decreased tolerance and increased immune response
(Jostins et al., 2012; Buttó et al., 2015; Liu et al., 2015).
Changes in resident microbiota composition following antibiotic
treatment or other stressors (e.g., inflammation, Lupp et al., 2007)
may favor the proliferation of pathogens, such as C. difficile,
Enterococcus, Salmonella, and Escherichia species (Keeney and
Finlay, 2011; Ng et al., 2013) causing further dysbiosis. These
bacteria were found to efficiently utilize the nutrients in the
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gut environment and, at least in the case of Salmonella,
be able to simultaneously implement adhesion mechanisms
and bacteriotoxin production to, respectively, resist the host
immunity and outcompete the resident microbiota (Raffatellu
et al., 2009; Winter et al., 2010). IBD patients may also suffer the
outgrowth of opportunistic pathogens or pathobionts, as a result
of their unbalanced microbiota. Unlike the pathogens described
above, these species are normally found within the human GI
microbiota, yet they are kept under control. The imbalance
of dysbiosis however, may favor their proliferation and the
expression and/or proliferation of their virulent traits. Among
these pathobionts were identified species of Klebsiella, Proteus,
and Escherichia (Darfeuille-Michaud et al., 2004; Baumgart et al.,
2007; Lupp et al., 2007; Walters et al., 2014; Buttó et al.,
2015).
Finally, the high levels of inflammation characterizing IBD
likely affect the microbiota as they do the host, inducing
molecular and physiological changes. It was found that in
response to harsh environments E. coli—which is found enriched
in IBD patients (Table 1)—could up-regulate the ibpA and
ibpB genes belonging to the stress response regulon, which
are involved in cell division, signal transduction and intestinal
adhesion (Zuckert, 2014; Tao et al., 2015). In the IL10−/− IBD
model mouse inoculated with a murine isolate of colitis-inducing
E. coli (NC101), ibpA and ibpB were found to be activated,
presumably to cope with the high amounts of reactive oxygen
species induced by intestinal inflammation and—possibly—
by the increased temperature caused by inflammation (Patwa
et al., 2011). Surprisingly, this response impaired E. coli luminal
growth and decreased survival after macrophage phagocytosis,
which seemed counter-intuitive (ib.). While these observations
may be partially limited due to the use of a monoassociated
mouse and the focus on luminal bacteria, they indicate that the
microbiota is rapidly and dynamically responding to the host
conditions.
FECAL TRANSPLANTATION
Recognizing that gut microbes are so integral to human health,
the prospect of reconstituting a healthy microbiota in cases
of dysbioses or disease becomes particularly attractive. Fecal
microbiota transplantation (FMT) aims at reversing altered
microbiota to their native state or one with healthy functionality.
In FMT intestinal microbiota obtained from a healthy donor
is processed, standardized and finally transplanted into the
intestine of a recipient. FMT is being considered in alternative
to antibiotic therapy to treat chronic C. difficile infections
(CDI) that occur in dysbioses. The United States record over
500,000 annual cases of CDI, making it the leading cause of
nosocomial diarrhea which, untreated, can result in lethal toxic
megacolon (Bakken et al., 2011). Aggressive antibiotic therapies
have produced chronic conditions with antibiotic resistant and
hyper-virulent C. difficile strains overtaking a severely depleted
GI microbiota (Cammarota et al., 2014; Khoruts, 2014). The
current treatment for CDI is oral vancomycin administration,
despite dwindling efficacies and a recorded 20–60% relapse
within the first month following the completion of the course
of vancomycin (Brandt et al., 2011). With limited options to
eradicate C. difficile infections, FMT seems a viable alternative
for restoring a healthy GI microbiota while avoiding the
undesirable effects of antibiotics. CDI characteristic dysbiosis
revealed dominating Gammaproteobacteria and Bacilli and rare
Clostridia and Bacteroidetes, which were instead abundant in
normal GI microbiota (Shankar et al., 2014). 16S rRNA profiling
of the fecal bacteria following FMT showed apparent restoration
of the microbial community and absence of C. difficile (Seekatz
et al., 2014; Shankar et al., 2014). The decreased symptoms and
clinical improvements remained stable for at least four months
post procedure (Shankar et al., 2014), while FMT re-established
a GI microbiota whose composition shifted from the diseased
state and resembled more that of the donor (ib.). These landmark
studies reported an impressive 90% success rate in reducing
the debilitating CDI symptoms in a small patient cohort. The
enthusiasm was tempered by finding much rarer successes in
severe CDI (Zainah et al., 2014), albeit the procedure appeared
safe and successful in appropriately chosen patients (Chapman
et al., 2016). Although the transplanted microbiota appeared to
generate a healthier microbiota taxonomy and could resolve the
CDI symptoms (Bakken, 2009; van Nood et al., 2013; Zainah
et al., 2014), many aspects of FMT demand further analyses and
larger clinical studies. A better definition of the composition(s)
of healthy gutmicrobiota and further understanding of how FMT
affects the GImicrobial community, its physiological interactions
with the patient and how long the changed microbiota is
maintained in the patients will all contribute to the further
development of this procedure (Bakken, 2009; Brandt, 2013;
Cammarota et al., 2014; Colman and Rubin, 2014; Khoruts and
Weingarden, 2014; Moayyedi et al., 2014; Zainah et al., 2014; Dai
et al., 2015).
CONCLUDING REMARKS
Convincing accumulating evidence shows that the human gut
microbiota contributes to many aspects of human health via
molecular pathways that we only begin to understand. The GI
microbiota entertains deep mutualistic relationships and co-
evolves with the human host, albeit at a much faster rate and
demonstrates deep ecological links with the host which are
being studied at the interface between Biology, Ecology, and
Medicine. Experimental probing of the deep and reciprocal
ties characterizing the microbiota-host relationship constitutes
a formidable challenge, yet holds the promise to shed light
on unknown aspects of human and microbial physiology
and novel therapeutic possibilities in the manipulation of
microbiota composition via antibiotics, probiotics, andmicrobial
transplantation. Progress in microbiota studies and the recent
discovery of the first new antibiotic in 30 years isolated
from the pool of “un-culturable bacteria” (Ling et al., 2015)
rekindle the hopes to find new therapeutics less prone to
elicit microbial resistance. Because of the trophic relationships
between host and gut microorganisms, dietary manipulation
to supply appropriate nutrients favoring specific classes of
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beneficial microorganism may also aid future therapies for
chronic pathologies displaying gut dysbiosis, such as asthma,
IBD, and RA.
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